Horiba, Ltd.
121.00
EUR
-6.00
(-4.72%)
ISIN
JP3853000002
Return %
Stock
S&P 500
1Y
63.51
14.20
3Y
151.04
81.12
5Y
116.07
68.34
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.Company Description
- CEO
- Atsushi Horiba
- Full Time Employees
- 9,101
- Sector
- Producer manufacturing
- Industry
- Industrial machinery
- Address
- 2 Miyanohigashi Kyoto KYT Japan 601-8510
- IPO Date
- Mar 22, 1971
- Website
- horiba.co.jp
- Similar Companies
- Business
- HORIBA, Ltd. (6856.T) manufactures and sells advanced analytical and measurement instruments and systems worldwide. The company operates through five primary segments—Automotive, Process/Environment, Medical, Semiconductor, and Scientific—offering engine emission measurement devices; in-use, on-board, and in-vehicle exhaust gas analyzers; driveline, brake, fuel cell, and battery test systems; environmental monitoring instruments for water quality, air quality, and industrial processes; in-vitro medical diagnostic analyzers including hematology systems and reagents; semiconductor wafer inspection systems, mass flow controllers, and process control equipment; as well as scientific spectrometers, Raman instruments, and fluorescence spectroscopy solutions for R&D, quality control, and applications in life sciences, materials, energy, and pharmaceuticals. HORIBA serves diverse sectors including automotive R&D, energy solutions, semiconductor manufacturing, medical diagnostics, and environmental management, with target markets encompassing hydrogen energy, connected vehicles, power generation, food and beverages, and waste management. Founded in 1945 and headquartered in Kyoto, Japan, the company maintains extensive global operations across more than 20 countries including the United States, China, Germany, India, Malaysia, and the United Kingdom. Recent developments include the acquisition of EtaMax Co., Ltd. in South Korea in 2025 to bolster semiconductor wafer inspection capabilities through integration of spectroscopy and defect detection technologies; establishment of a new production base in Kedah, Malaysia, by subsidiary HORIBA Malaysia Sdn Bhd, with operations commencing in January 2026 to strengthen the global supply chain for semiconductor products; opening of a medical equipment manufacturing facility in Nagpur, India, focused on hematology reagents and mass flow controllers with plans for further expansion into neighboring countries; and reporting consolidated net sales of 317,369 million yen for the year ended December 31, 2024, alongside 8,955 consolidated employees.
Company News
Oasis Views HORIBA's 2026 AGM Results as Clear Warning to the Board
Oasis Calls on HORIBA Shareholders to Vote Against Chairman Atsushi Horiba at the 2026 Annual General Meeting
Contrasting Horiba (OTCMKTS:HRIBF) and JE Cleantech (NASDAQ:JCSE)
Horiba (OTCMKTS:HRIBF) versus Global Industrial (NYSE:GIC) Critical Analysis
Analyzing DMC Global (NASDAQ:BOOM) & Horiba (OTCMKTS:HRIBF)
Analyzing Horiba (OTCMKTS:HRIBF) & DMC Global (NASDAQ:BOOM)
Comparing Horiba (OTCMKTS:HRIBF) & Presidio Property Trust (NASDAQ:SQFT)
Financial Contrast: Kion Group (OTCMKTS:KIGRY) and Horiba (OTCMKTS:HRIBF)
Comparing Horiba (OTCMKTS:HRIBF) & Pressure Biosciences (OTCMKTS:PBIO)